Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Iontophoretic Application of Acyclovir Gel to Treat Cold Sores

ClinicalTrials.gov ID: NCT00469300

Public ClinicalTrials.gov record NCT00469300. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of the Electrokinetic Transdermal System (ETS) With Acyclovir Gel for the Episodic Treatment of Herpes Labialis

Study identification

NCT ID
NCT00469300
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Transport Pharmaceuticals
Industry
Enrollment
810 participants

Conditions and interventions

Interventions

  • Iontophoretic delivery of acyclovir Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2007
Primary completion
Aug 31, 2007
Completion
Sep 30, 2007
Last update posted
Feb 3, 2008

2007

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Radiant Research Birmingham Birmingham Alabama 35209
Radiant Research Santa Rosa Santa Rosa California 95405
Radiant Research St. Petersburg Pinellas Park Florida 33781
Radiant Research Chicago Chicago Illinois 60610
Radiant Research Minneapolis Edina Minnesota 55435
Radiant Research St. Louis St Louis Missouri 63141
Rochester Clinical Research, Inc. Rochester New York 14609
Radiant Research Cincinnati Cincinnati Ohio 45236
Radiant Research Akron Mogadore Ohio 44260
OMEGA Medical Research Warwick Rhode Island 02886
Radiant Research Greer Greer South Carolina 29651
Radiant Research Dallas North Dallas Texas 75231
Radiant Research San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00469300, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2008 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00469300 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →